Merus N.V. (MRUS) vs Protagonist Therapeutics, Inc. (PTGX)
Detailed comparison between Merus N.V., Protagonist Therapeutics, Inc..Total Return (%)
Merus N.V. (MRUS)Protagonist Therapeutics, Inc. (PTGX)
Which stock do you think will perform better?
Merus N.V.
MRUS
Protagonist Therapeutics, Inc.
PTGX
| Metric | Merus N.V. (MRUS) | Protagonist Therapeutics, Inc. (PTGX) |
|---|---|---|
| Current Price | $95.98 | $84.20 |
| Change | -0.06 (-0.06%) | -0.93 (-1.09%) |
| Market Cap | $7.28B | $5.26B |
| Trailing P/E | 0.00 | 127.58 |
| Forward P/E | -24.61 | -58.88 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $96.28 | $93.25 |
| 52-Week Low | $33.19 | $33.70 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.28 | $0.66 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| MRUS | 1.67% | 136.23% | 110.99% | 504.03% | 855.98% | 855.98% |
| PTGX | 14.56% | 128.31% | 81.23% | 281.86% | 619.66% | 619.66% |